BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 12895609)

  • 21. [Effectiveness of endovascular prostheses as initial treatment for superior vena cava syndrome of malignant cause].
    Talens A; Ferrer S; González-Cruz A; Blanco E; García-Ferrer L; Iranzo V; Camps C
    Med Clin (Barc); 2013 Jan; 140(2):59-65. PubMed ID: 22237043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombosis, anticoagulation and outcomes in malignant superior vena cava syndrome.
    Ratzon R; Tamir S; Friehmann T; Livneh N; Dudnik E; Rozental A; Hamburger-Avnery O; Pereg D; Derazne E; Brenner B; Raanani P; Ten Cate H; Spectre G; Leader A
    J Thromb Thrombolysis; 2019 Jan; 47(1):121-128. PubMed ID: 30255420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous Endovascular Stent Placement for Treatment of Malignant Superior Vena Cava Syndrome: A Retrospective Review.
    Wu Y; Li Y; Wang M; Li W; Qiu X
    Ann Vasc Surg; 2022 Mar; 80():325-332. PubMed ID: 34780937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant superior vena cava syndrome: a comparative cohort study of treatment with covered stents versus uncovered stents.
    Gwon DI; Ko GY; Kim JH; Shin JH; Yoon HK; Sung KB
    Radiology; 2013 Mar; 266(3):979-87. PubMed ID: 23249571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malignant obstruction of superior vena cava: Endovascular stenting using Y-configuration stent in stent technique.
    Noor Khairiah AK; Mohamad Nazrulhisham MN; Hazman MN
    Med J Malaysia; 2018 Dec; 73(6):407-409. PubMed ID: 30647215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endovascular treatment of malignant superior vena cava syndrome: is bilateral wallstent placement superior to unilateral placement?
    Dinkel HP; Mettke B; Schmid F; Baumgartner I; Triller J; Do DD
    J Endovasc Ther; 2003 Aug; 10(4):788-97. PubMed ID: 14533962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A retrospective stenting study on superior vena cava syndrome caused by lung cancer.
    Wei S; Liu J; Li X; Song Z; Dong M; Zhao H; Zhao Q; Chen G; Chen J
    Thorac Cancer; 2020 Jul; 11(7):1835-1839. PubMed ID: 32438532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endovascular Treatment of Malignant Superior Vena Cava Syndrome through Upper-Limb Access: A Comparison between Venous-Dedicated and Conventional Stents.
    Matthaiou N; Galanakis N; Kehagias E; Kontopodis N; Charalambous S; Kholcheva N; Tsetis K; Mavroudis D; Tsetis D
    J Vasc Interv Radiol; 2020 Dec; 31(12):2066-2072. PubMed ID: 33127247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Observation of endovascular stent insertion for non-small cell lung cancer patients with superior vena cava syndrome].
    Li F; Sun X; Liang S; Jiang S; Mao L
    Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):47-51. PubMed ID: 25877319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of malignant obstruction of the superior vena cava with the self-expanding Wallstent.
    Stock KW; Jacob AL; Proske M; Bolliger CT; Rochlitz C; Steinbrich W
    Thorax; 1995 Nov; 50(11):1151-6. PubMed ID: 8553270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stent placement for the treatment of malignant superior vena cava syndrome - a single-center series of 56 patients.
    Sobrinho G; Aguiar P
    Arch Bronconeumol; 2014 Apr; 50(4):135-40. PubMed ID: 24360084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid Fire: Superior Vena Cava Syndrome.
    Zimmerman S; Davis M
    Emerg Med Clin North Am; 2018 Aug; 36(3):577-584. PubMed ID: 30037444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retrospective study in 23 patients of the self-expanding sinus-XL stent for treatment of malignant superior vena cava obstruction caused by non-small cell lung cancer.
    Mokry T; Bellemann N; Sommer CM; Heussel CP; Bozorgmehr F; Gnutzmann D; Kortes NA; Kauczor HU; Radeleff B; Stampfl U
    J Vasc Interv Radiol; 2015 Mar; 26(3):357-65. PubMed ID: 25638748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of malignant superior vena cava syndrome by endovascular stent insertion. Experience on 52 patients with lung cancer.
    Urruticoechea A; Mesía R; Domínguez J; Falo C; Escalante E; Montes A; Sancho C; Cardenal F; Majem M; Germà JR
    Lung Cancer; 2004 Feb; 43(2):209-14. PubMed ID: 14739042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Superior vena cava obstruction: is stenting necessary?
    Marcy PY; Magné N; Bentolila F; Drouillard J; Bruneton JN; Descamps B
    Support Care Cancer; 2001 Mar; 9(2):103-7. PubMed ID: 11305067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stent placement in superior vena cava syndrome.
    Courtheoux P; Alkofer B; Al Refaï M; Gervais R; Le Rochais JP; Icard P
    Ann Thorac Surg; 2003 Jan; 75(1):158-61. PubMed ID: 12537210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of superior vena cava syndrome in cancer patients with intravascular stent and local thrombolysis].
    Zhang F; Wu P; Huang J
    Zhonghua Zhong Liu Za Zhi; 2000 Nov; 22(6):507-9. PubMed ID: 11235576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of endovascular stenting for superior vena cava syndrome in fibrosing mediastinitis.
    Deshwal H; Ghosh S; Magruder K; Bartholomew JR; Montgomery J; Mehta AC
    Vasc Med; 2020 Apr; 25(2):174-183. PubMed ID: 31804157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term results of endovascular stent placement in the superior caval venous system.
    Smayra T; Otal P; Chabbert V; Chemla P; Romero M; Joffre F; Rousseau H
    Cardiovasc Intervent Radiol; 2001; 24(6):388-94. PubMed ID: 11907745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stenting through a portacath for totally occluded superior vena cava in a case of non-Hodgkin s lymphoma.
    Patel TM; Shah SC; Ranjan A; Malhotra H; Patel R; Gupta AK
    J Invasive Cardiol; 2003 Feb; 15(2):86-8. PubMed ID: 12556622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.